Group One Trading
BTTX

Group One Trading’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Group One Trading’s Portfolio BTTX Stock Details BTTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,000
Closed -$1.46K – 8357
2023
Q1 		$1.46K Sell
2,000
-48,700
-96% -$57.2K ﹤0.01% 6688
2022
Q4 		$56.8K Sell
50,700
-8,200
-14% -$12.1K ﹤0.01% 4890
2022
Q3 		$104K Buy
58,900
+26,900
+84% +$49.1K ﹤0.01% 4745
2022
Q2 		$50K Buy
+32,000
New +$53.5K ﹤0.01% 5558

Other funds holding BTTX

CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return

Group One Trading's BTTX Position: Q1 2024 in Review

Group One Trading sold out of Better Therapeutics, Inc. Common Stock (BTTX) in Q1 2024, closing a stake of 10,351 shares — an estimated $2.02K sold.

Group One Trading first reported a position in BTTX in Q4 2022 and held it in 5 quarters. The position peaked at $22.7K in Q4 2022. 3 funds tracked by Wall St. Rank hold BTTX as of Q1 2024.

  • Group One Trading reported no remaining Better Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 10,351 Better Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.02K.
  • Group One Trading first reported a position in Better Therapeutics, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
  • Group One Trading's Better Therapeutics, Inc. Common Stock position peaked at $22.7K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Better Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.